The largest genomics study of chordoma to date has discovered a gene mutation possessed by some patients which is a target for existing drugs known as PI3K inhibitors. Previously, these drugs have not been considered for chordoma.
Researchers from the University of Southern California Roski Eye Institute (CA, USA) have derived genetic information from retinoblastoma tumors without removing the eye.
Nivolumab has been given the green light for nivolumab for head and neck cancer via the Cancer Drug Fund.
Discover preliminary data for a new assay workflow to detect the presence of PD-L1 and PD-L2 on the surface of tumor cells that have broken away from the tumor and entered the blood in this research article from Future Science OA.
How could the epigenome serve as a promising therapeutic target in reversing cancer-associated muscle catabolism? Find out in this commentary article from Epigenomics.
In this perspective paper, discover three pictorial models that are designed to help offer patients focus and belief when combating cancer in their lives to allow them to embrace hope with greater confidence, which minimizes their grief.